USFDA approved Cipla for hypertension and cardiac conditions drug

Posted on:30 Oct 2018 16:53:47
USFDA approved Cipla for hypertension and cardiac conditions drug
30 October 2018 Current Affairs: Cipla, a major drug firm, received final approval from the United Nations Food and Drug Administration (USFDA), the U.S. health regulator to market Metoprolol tablets. The drug is used to treat hypertension and various cardiac conditions. The strengths of the drug are 50mg, 100mg and 200mg.
Cipla, a major drug firm, received final approval from the United Nations Food and Drug Administration (USFDA), the U.S. health regulator to market Metoprolol tablets. The drug is used to treat hypertension and various cardiac conditions. The strengths of the drug are 50mg, 100mg and 200mg.

Monthly Current Affairs

Current Affairs Section

Daily Current Affairs Quiz

Subscribe to Current Affairs

Enter your email to get daily current affairs

Currentt Affairs 2018 November

22 NOVEMBER
NEWS
21 NOVEMBER
NEWS
20 NOVEMBER
NEWS
19 NOVEMBER
NEWS

Currentt Affairs 2018 October

31 OCTOBER
NEWS
30 OCTOBER
NEWS
29 OCTOBER
NEWS
28 OCTOBER
NEWS

Currentt Affairs 2018 September

30 SEPTEMBER
NEWS
29 SEPTEMBER
NEWS
28 SEPTEMBER
NEWS
27 SEPTEMBER
NEWS